Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Comparing vasopressin and norepinephrine for treating low blood pressure after heart surgery

Official title: Inotropic Effects of Vasopressin Versus Noradrenaline In Patients With Vasoplegic Syndrome After Cardiac Surgery

Run by University of Sao Paulo · NCT06934798 · Data updated 2026-11-12

This study is testing whether vasopressin or norepinephrine works better to treat low blood pressure in patients who develop complications after heart surgery.

More Vasoplegic Syndrome of Cardiac Surgery trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment350 (estimated)
SponsorUniversity of Sao Paulo
Academic / other
Locations1 site (São Paulo)
StatusRecruiting
StartedApril 1, 2024
Main results expectedJuly 30, 2025
Study endsJuly 30, 2025
Registry record updatedApril 30, 2025
Trial IDNCT06934798 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 undergoing coronary artery bypass grafting or valve surgery who develop vasoplegic syndrome within 24 hours postoperatively.

Probably not a fit

Patients who have undergone aortic surgery, heart transplants, or emergency surgeries, or those with certain postoperative complications, will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial is a randomized, double-blind investigation comparing the effects of vasopressin versus norepinephrine in patients who develop vasoplegic syndrome shortly after cardiac surgery. Vasoplegic syndrome leads to severe low blood pressure despite adequate fluid resuscitation, and this study aims to determine which vasopressor is more effective in improving cardiac output and hemodynamic stability. Eligible patients will receive either vasopressin or norepinephrine, with their responses monitored through various echocardiographic and hemodynamic parameters. The findings could help refine treatment protocols for managing this serious postoperative complication.

Why it matters

Potential benefit: If successful, this study could lead to improved management of vasoplegic syndrome, enhancing patient outcomes after cardiac surgery.

How similar studies have gone: While norepinephrine is the standard treatment, the exploration of vasopressin as an alternative is relatively novel, and previous studies have shown mixed results regarding its efficacy.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age over 18.
* Patients undergoing coronary artery bypass grafting, valve surgery or both, with a diagnosis of vasoplegic syndrome in the immediate postoperative period (\<24 hours), defined as mean arterial pressure \< 65 mmHg (measured using an invasive blood pressure catheter) and resistance to fluid replacement - at least 1000ml of crystalloids.

Exclusion Criteria:

* Pregnancy or breastfeeding.
* Aortic surgery.
* Surgeries to correct congenital heart disease.
* Heart transplants.
* Emergency surgery.
* Use of vasopressor therapy in the preoperative period.
* Presence of a ventricular assist device other than an intra-aortic balloon in the postoperative period.
* Severe hyponatremia in the postoperative period (serum sodium less than 130mEq/l).
* Postoperative acute coronary syndrome.
* Mesenteric ischemia in the postoperative period.
* History of Raynaud's disease.
* History of neoplasia.

Where it's running

  • Instituto do Coração HCFMUSP
    São Paulo, Brazil
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.